DOWNERS GROVE, Ill., April 4, 2019 /CNW/ -- Univar Inc. (NYSE: UNVR) ("Univar Solutions"), a global chemical and ingredient distributor and provider of value-added services, announced today that Novozymes has chosen Univar Solutions' NexusAg as the sole distributor for its downstream BioYield enhancers in Canada, which represents a significant portion of the biological products portfolio. The agreement will go into effect at the end of June 2019 and does not cover JumpStart® XL and BioRise™ offerings, which will remain with Bayer.
As an established leader in bioinnovation, Novozymes brings a unique dedication to enzymes as well as microbes. Its line of BioYield enhancers are derived from naturally occurring microbes and act as microbial inoculants to complement traditional fertilizers and ultimately improve crop yields for the agricultural industry.
"We are very excited to partner with Univar Solutions in continuing to deliver our leading inoculant products in Canada," said Thomas Batchelor, vice president, BioAg commercial at Novozymes. "Univar Solutions has been a great partner to Novozymes across our business segments over many years, and we firmly believe they will also be a strong partner in our key, Canadian BioAg business. Alongside our continued partnership with Bayer and new partnership with UPL, both announced earlier today, we believe we have the right partner base to enable us to continue our goal of delivering effective, microbial solutions to help farmers with their challenges in feeding a growing world more sustainably."
Univar Solutions' NexusAg will provide a dedicated sales presence that is focused on bringing superior market intelligence data and analytics to predict trends and drive growth.
"Univar Solutions has demonstrated an unwavering commitment to bringing value driven products and brands to an increasingly advanced world of 'smart farming', said Neil Douglas, vice president of agriculture for Univar Solutions. "We are incredibly excited to further demonstrate this commitment through such a well-known and widely respected company as Novozymes and look forward to managing and distributing their main downstream BioYield products in the pulse-driven Canadian market."
About Univar Solutions
Univar Solutions (NYSE: UNVR) is a leading global chemical and ingredient distributor and provider of value added services to customers across a wide range of industries. With the industry's largest private transportation fleet and North American sales force, a vast supplier network, deep market and regulatory knowledge, world-class formulation and recipe development, unparalleled logistics know-how, and industry-leading digital tools, Univar Solutions is a committed ally to customers and suppliers, helping them anticipate, navigate, and leverage meaningful growth opportunities. Learn more at www.univarsolutions.com.
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com.
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond our control. We caution you that the forward-looking information presented in this press release is not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "plan," "seek," "comfortable with," "will," "expect," "intend," "estimate," "anticipate," "believe" or "continue" or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and we do not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.
SOURCE Univar Inc.
For further information: David Lim, Investor Relations, +1 844-632-1060, IR@univar.com, or Dwayne Roark, Media Relations, +1 331-777-6031, email@example.com, http://www.univarcorp.com